Market Overview

Benzinga's Top Initiations

Share:
Benzinga's Top Initiations
Related ALB
Albemarle Accelerates Toward De-Levering, Growth Story On Track
Albemarle's Sale Of Surface Treatment Unit 'Furthers Compelling Lithium Growth Story'
The Lithium Boom - An Analysis Of Future Demand Vs. Supply (Seeking Alpha)
Related INSY
5 Stocks Moving In Friday's After-Hours Session
Roddy Boyd Nailed Insys Therapeutics Thesis
GW Pharma Jumps As Cannabis Drug Treats Severe Epilepsy (Investor's Business Daily)

Analysts at Topeka Capital initiated coverage on shares of Albemarle (NYSE: ALB) with a “hold” rating. The target price for Albemarle is set to $67. Albemarle's shares closed at $61.88 yesterday.

Oppenheimer initiated coverage on shares of Insys Therapeutics (NASDAQ: INSY) with an “outperform” rating. The target price for Insys Therapeutics is set to $23. Insys Therapeutics's stock closed at $16.05 yesterday.

SunTrust Robinson Humphrey initiated coverage on shares of Goodrich Petroleum (NYSE: GDP) with a “buy” rating. The target price for Goodrich Petroleum is set to $25. Goodrich Petroleum's shares closed at $17.97 yesterday.

Analysts at Credit Suisse initiated coverage on shares of Sunesis Pharmaceuticals (NASDAQ: SNSS) with a “buy” rating. The target price for Sunesis Pharmaceuticals is set to $25. Sunesis's shares closed at $5.40 yesterday.

Latest Ratings for ALB

DateFirmActionFromTo
May 2016CitigroupMaintainsBuy
May 2016Deutsche BankMaintainsBuy
May 2016JefferiesMaintainsBuy

View More Analyst Ratings for ALB
View the Latest Analyst Ratings

Posted-In: Top InitiationsInitiation Analyst Ratings

 

Related Articles (ALB + GDP)

View Comments and Join the Discussion!